Matching articles for "Eprex"
Issue 1722 · February 17, 2025
Vadadustat (Vafseo) for Anemia of Chronic Kidney Disease

The FDA has approved the hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) vadadustat ( Vafseo – Akebia) for oral treatment of anemia due to chronic kidney disease (CKD) in adults who have been…

Med Lett Drugs Ther. 2025 Feb 17; 67(1722):27-9 doi:10.58347/tml.2025.1722b
The FDA has approved the hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) vadadustat ( Vafseo – Akebia) for oral treatment of anemia due to chronic kidney disease (CKD) in adults who have been on dialysis for at least 3 months. Vadadustat is the second HIF-PHI to be approved in the US for this indication; daprodustat (Jesduvroq) was approved earlier, but it was withdrawn from the US market in 2024 for commercial reasons.
Issue 1301 · December 15, 2008 Free
Drugs That May Cause Psychiatric Symptoms

Many drugs can cause psychiatric symptoms, but a causal connection is often difficult to establish. Psychiatric symptoms that emerge during drug treatment could also be due to the underlying illness,…

Med Lett Drugs Ther. 2008 Dec 15; 50(1301):100-3
Many drugs can cause psychiatric symptoms, but a causal connection is often difficult to establish. Psychiatric symptoms that emerge during drug treatment could also be due to the underlying illness, previously unrecognized psychopathology, or psychosocial factors. The withdrawal of some drugs can cause symptoms such as anxiety, psychosis, delirium, agitation or depression. Click here to view the free full article.
Issue 1120 · December 10, 2001
Darbepoetin (Aranesp) - A long-acting Erythropoietin

Darbepoetin alfa (Aranesp) has been approved by the FDA for treatment of anemia caused by chronic renal disease and will probably also be approved for use in patients with cancer..

Med Lett Drugs Ther. 2001 Dec 10; 43(1120):109-10
Darbepoetin alfa (Aranesp) has been approved by the FDA for treatment of anemia caused by chronic renal disease and will probably also be approved for use in patients with cancer..
Issue 824 · August 10, 1990
Drugs for Viral Infections
Med Lett Drugs Ther. 1990 Aug 10; 32(824):73-8
Issue 811 · February 9, 1990
Drugs for HIV Infection
Med Lett Drugs Ther. 1990 Feb 9; 32(811):11-2
Issue 800 · September 8, 1989
Carboplatin

Carboplatin ( Paraplatin - Bristol-Myers), a cytotoxic platinum-containing drug chemically related to cisplatin ( Platinol ), was recently approved by the US Food and Drug Administration (FDA) for palliative…

Med Lett Drugs Ther. 1989 Sep 8; 31(800):83-4
Carboplatin ( Paraplatin - Bristol-Myers), a cytotoxic platinum-containing drug chemically related to cisplatin ( Platinol ), was recently approved by the US Food and Drug Administration (FDA) for palliative treatment of patients with recurrent ovarian cancer, including those previously treated with cisplatin.